Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
infectious disease
Biotech
GSK's bet on rejected UTI antibiotic pays off with phase 3 win
GSK’s decision to swoop in and save Spero Therapeutics’ antibiotic three years ago appears to have paid off based on a fresh phase 3 readout.
James Waldron
May 28, 2025 8:42am
Fierce Healthcare
Court blocks HHS RIF again after Trump's Supreme Court appeal
May 23, 2025 10:30am
Armata links bacteria-killing virus to responses in phase 2
May 19, 2025 8:41am
Trump aims to block pathogen research, citing ‘lab leak’ theory
May 6, 2025 9:05pm
Ex-FDA leader joins new initiative aiming to protect vaccine use
Apr 24, 2025 1:18pm
Alopexx seeks IPO to advance ex-Sanofi infectious disease drug
Feb 26, 2025 10:04am